Form SD SASOL LTD
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sasol Ltd. (SOL:SJ) (SSL) PT Raised to ZAR198 at Goldman Sachs
- Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
- ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share